CISPLATIN, OXALIPLATIN, PACLITAXEL, AND DOCETAXEL: A COMPARATIVE ANALYSIS

Platinum-based chemotherapy agents, such as cisplatin and oxaliplatin, have demonstrated efficacy in treating a range of malignancies. Furthermore, their inherent toxicity necessitates the exploration of alternative or adjunctive therapeutic modalities. Paclitaxel and docetaxel, representing the taxane class, have emerged as potent antitumor agents